Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent

Neurobiology of Aging

Volumn 36, Issue 3, 2015, Pages 1496-1504

  Orr, Miranda E ^a   Garbarino, Valentina R ^a   Salinas, Angelica ^a   Buffenstein, Rochelle ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aging; Alzheimer's disease; Animal model; Naked mole rat; Phosphorylation; Tau

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ADULT; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN DEVELOPMENT; CONTROLLED STUDY; MICROTUBULE ASSEMBLY; MOLECULAR WEIGHT; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; AXON; BRAIN; DISEASE MODEL; GENETICS; LONGEVITY; METABOLISM; MOLE RAT; PATHOLOGY; PHOSPHORYLATION; TAUOPATHY; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AXONS; BRAIN; DISEASE MODELS, ANIMAL; LONGEVITY; MICE, TRANSGENIC; MOLE RATS; MOLECULAR WEIGHT; PHOSPHORYLATION; TAU PROTEINS; TAUOPATHIES;

EID: 84923539340     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.12.004     Document Type: Article

References (51)

1. Ahmed T., Van der Jeugd A., Blum D., Galas M.C., D'Hooge R., Buee L., Balschun D. Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion. Neurobiol. Aging 2014, 35:2474-2478.
2. Ando K., Leroy K., Heraud C., Yilmaz Z., Authelet M., Suain V., De Decker R., Brion J.P. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. Am. J. Pathol. 2011, 178:803-816.
3. Andorfer C., Kress Y., Espinoza M., de Silva R., Tucker K.L., Barde Y.A., Duff K., Davies P. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J.Neurochem. 2003, 86:582-590.
4. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992, 42(3 Pt 1):631-639.
5. Beccano-Kelly D.A., Kuhlmann N., Tatarnikov I., Volta M., Munsie L.N., Chou P., Cao L.-P., Han H., Tapia L., Farrer M.J., Milnerwood A.J. Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice. Front. Cell. Neurosci. 2014, 8:301-311.
6. Bickler P.E., Fahlman C.S., Taylor D.M. Oxygen sensitivity of NMDA receptors: relationship to NR2 subunit composition and hypoxia tolerance of neonatal neurons. Neuroscience 2003, 118:25-35.
7. Biernat J., Gustke N., Drewes G., Mandelkow E.M., Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 1993, 11:153-163.
8. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993, 10:1089-1099.
9. Brion J.P., Smith C., Couck A.M., Gallo J.M., Anderton B.H. Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J.Neurochem. 1993, 61:2071-2080.
10. Brody D.L., Magnoni S., Schwetye K.E., Spinner M.L., Esparza T.J., Stocchetti N., Zipfel G.J., Holtzman D.M. Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 2008, 321:1221-1224.
11. Buffenstein R. Ecophysiological responses of subterranean rodents to underground habitats. Life Underground, the Biology of Subterranean Rodents 2001, 62-110. University of Chicago Press, Chicago. E.A. Lacey, J.L. Patton, G.N. Cameron (Eds.).
12. Burek M.J., Oppenheim R.W. Programmed cell death in the developing nervous system. Brain Pathol. 1996, 6:427-446.
13. Creamer J.S., Oborny N.J., Lunte S.M. Recent advances in the analysis of therapeutic proteins by capillary and microchip electrophoresis. Anal. Methods 2014, 6:5427-5449.
14. Cruz J.C., Tsai L.H. AJekyll and Hyde kinase: roles for Cdk5 in brain development and disease. Curr. Opin. Neurobiol. 2004, 14:390-394.
15. Dawson H.N., Cantillana V., Jansen M., Wang H., Vitek M.P., Wilcock D.M., Lynch J.R., Laskowitz D.T. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease. Neuroscience 2010, 169:516-531.
16. Dujardin S., Lecolle K., Caillierez R., Begard S., Zommer N., Lachaud C., Carrier S., Dufour N., Auregan G., Winderickx J., Hantraye P., Deglon N., Colin M., Buee L. Neuron-to-neuron wild-type tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathol. Commun. 2014, 2:14.
17. Edrey Y.H., Medina D.X., Gaczynska M., Osmulski P.A., Oddo S., Caccamo A., Buffenstein R. Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease. Neurobiol. Aging 2013, 34:2352-2360.
18. Edrey Y.H., Oddo S., Cornelius C., Caccamo A., Calabrese V., Buffenstein R. Oxidative damage and amyloid-beta metabolism in brain regions of the longest-lived rodents. J.Neurosci. Res. 2014, 92:195-205.
19. Giuffrida M.L., Caraci F., Pignataro B., Cataldo S., De Bona P., Bruno V., Molinaro G., Pappalardo G., Messina A., Palmigiano A., Garozzo D., Nicoletti F., Rizzarelli E., Copani A. Beta-amyloid monomers are neuroprotective. J.Neurosci. 2009, 29:10582-10587.
20. Goedert M., Crowther R.A., Garner C.C. Molecular characterization of microtubule-associated proteins tau and MAP2. Trends Neurosci. 1991, 14:193-199.
21. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989, 3:519-526.
22. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., Crowther R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 1989, 8:393-399.
23. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184-185.
24. Himmler A., Drechsel D., Kirschner M.W., Martin D.W. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol. Cell. Biol. 1989, 9:1381-1388.
25. Hirokawa N. Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr. Opin. Cel. Biol. 1994, 6:74-81.
26. Kenessey A., Yen S.H. The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments. Brain Res. 1993, 629:40-46.
27. Kim E.B., Fang X., Fushan A.A., Huang Z., Lobanov A.V., Han L., Marino S.M., Sun X., Turanov A.A., Yang P., Yim S.H., Zhao X., Kasaikina M.V., Stoletzki N., Peng C., Polak P., Xiong Z., Kiezun A., Zhu Y., Chen Y., Kryukov G.V., Zhang Q., Peshkin L., Yang L., Bronson R.T., Buffenstein R., Wang B., Han C., Li Q., Chen L., Zhao W., Sunyaev S.R., Park T.J., Zhang G., Wang J., Gladyshev V.N. Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature 2011, 479:223-227.
28. Kramer B., Buffenstein R. The pancreas of the naked mole-rat (Heterocephalus glaber): an ultrastructural and immunocytochemical study of the endocrine component of thermoneutral and cold acclimated animals. Gen. Comp. Endocrinol. 2004, 139:206-214.
29. Lee H.G., Perry G., Moreira P.I., Garrett M.R., Liu Q., Zhu X., Takeda A., Nunomura A., Smith M.A. Tau phosphorylation in Alzheimer's disease: pathogen or protector?. Trends Mol. Med. 2005, 11:164-169.
30. Lei P., Ayton S., Finkelstein D.I., Spoerri L., Ciccotosto G.D., Wright D.K., Wong B.X., Adlard P.A., Cherny R.A., Lam L.Q., Roberts B.R., Volitakis I., Egan G.F., McLean C.A., Cappai R., Duce J.A., Bush A.I. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 2012, 18:291-295.
31. Leroy K., Yilmaz Z., Brion J.P. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol. Appl. Neurobiol. 2007, 33:43-55.
32. Li H.L., Wang H.H., Liu S.J., Deng Y.Q., Zhang Y.J., Tian Q., Wang X.C., Chen X.Q., Yang Y., Zhang J.Y., Wang Q., Xu H., Liao F.F., Wang J.Z. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3591-3596.
33. Lindwall G., Cole R.D. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J.Biol. Chem. 1984, 259:5301-5305.
34. Martin L., Latypova X., Terro F. Post-translational modifications of tau protein: implications for Alzheimer's disease. Neurochem. Int. 2011, 58:458-471.
35. Martin L., Latypova X., Wilson C.M., Magnaudeix A., Perrin M.L., Yardin C., Terro F. Tau protein kinases: involvement in Alzheimer's disease. Ageing Res. Rev. 2013, 12:289-309.
36. Morsch R., Simon W., Coleman P.D. Neurons may live for decades with neurofibrillary tangles. J.Neuropathol. Exp. Neurol. 1999, 58:188-197.
37. Nguyen U., Squaglia N., Boge A., Fung P.A. The Simple Western: a gel-free, blot-free, hands-free Western blotting reinvention. Nat. Methods 2011, 8:v-vi.
38. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
39. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 1991, 14:453-501.
40. Ozansoy M.B., Baska A.N. Tauopathies: a distinct class of neurodegenerative diseases. BJMG 2007, 10:3-14.
41. Pacheco C.D., Elrick M.J., Lieberman A.P. Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis. Hum. Mol. Genet. 2009, 18:956-965.
42. Peterson B.L., Larson J., Buffenstein R., Park T.J., Fall C.P. Blunted neuronal calcium response to hypoxia in naked mole-rat hippocampus. PLoS One 2012, 7:e31568.
43. Peterson B.L., Park T.J., Larson J. Adult naked mole-rat brain retains the NMDA receptor subunit GluN2D associated with hypoxia tolerance in neonatal mammals. Neurosci. Lett. 2012, 506:342-345.
44. Rovelet-Lecrux A., Campion D. Copy number variations involving the microtubule-associated protein tau in human diseases. Biochem. Soc. Trans. 2012, 40:672-676.
45. Satoh Y., Endo S., Nakata T., Kobayashi Y., Yamada K., Ikeda T., Takeuchi A., Hiramoto T., Watanabe Y., Kazama T. ERK2 contributes to the control of social behaviors in mice. J.Neurosci. 2011, 31:11953-11967.
46. Spillantini M.G., Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013, 12:609-622.
47. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J.Q., Lee V.M. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp. Neurol. 2001, 168:402-412.
48. Wang J.Z., Grundke-Iqbal I., Iqbal K. Kinases and phosphatases and tau sitesinvolved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 2007, 25:59-68.
49. Wirths O., Bayer T.A. Neuron loss in transgenic mouse models of Alzheimer's disease. Int. J. Alzheimers Dis. 2010, 2010. pii: 723782. 10.4061/2010/723782.
50. Yuan J., Lipinski M., Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 2003, 40:401-413.
51. Zahs K.R., Ashe K.H. 'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?. Trends Neurosci. 2010, 33:381-389.